Research Protocol

Epithalon 10mg — Research Protocol

Quickstart Highlights

Epitalon (Epithalon) dosage protocols center on this synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from pineal gland research for its geroprotective potential[1]. Epitalon activates telomerase to promote telomere elongation, supports healthy melatonin production for improved sleep and circadian rhythm regulation, and has demonstrated lifespan extension in animal models[2][3]. Human studies suggest potential benefits for longevity, cardiovascular health, and physiological function in older adults[4].

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) for long-term; refrigerate at 2–8 °C (35.6–46.4 °F) for routine storage; minimize moisture exposure[6].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks and avoid freeze–thaw[7].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

How It Works

Epitalon’s primary mechanism involves telomerase activation, promoting telomere elongation in cells[2]. In vitro studies demonstrated that Epitalon induced telomerase and lengthened telomeres in human cell cultures, allowing cells to continue dividing beyond the usual Hayflick limit[9]. Epitalon also influences the neuroendocrine system by stimulating nocturnal melatonin release from the pineal gland, thereby normalizing circadian hormone rhythms in aged subjects[3]. Additional reported effects include antioxidant activity, genomic regulatory effects, and immune modulation[1].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Supports telomere maintenance and cellular longevity through telomerase activation[2][9].
  • Restores healthy melatonin production and circadian rhythm regulation[3].
  • Extended lifespan and reduced tumor incidence observed in animal models[1].
  • Human trials showed improved cardiovascular outcomes and reduced mortality over 12-year follow-up[4].
  • Generally well tolerated; no serious adverse events reported in long-term studies[5].
  • Occasional mild injection-site reactions or transient sleep pattern changes may occur.

References

For laboratory and research use only. Minimum 98% purity. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. This protocol is provided for educational and research purposes only and is not medical advice. The purchaser accepts full responsibility for safe handling, storage and lawful use.